Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Xa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00986635
What this trial is testing

Effect of Rivaroxaban on Coagulation Parameters- an ex Vivo Study

Who this might be right for
Differences in Laboratory Coagulation Parameters
Johann Wolfgang Goethe University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04640181
What this trial is testing

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

Who this might be right for
Covid19
St. David's HealthCare 150
Testing effectiveness (Phase 2)Ended earlyNCT01621243
What this trial is testing

M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Momenta Pharmaceuticals, Inc. 128
Not applicableStudy completedNCT01803022
What this trial is testing

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

Who this might be right for
Venous Thromboembolism
LEO Pharma 419
Large-scale testing (Phase 3)Study completedNCT00986154
What this trial is testing

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Who this might be right for
Venous ThromboembolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+2 more
Daiichi Sankyo 8,292
Not applicableNot Yet RecruitingNCT07168005
What this trial is testing

Informative Video Before LMWH Postpartum - Randomized Controlled Trial

Who this might be right for
Venous Thromboembolism (VTE)Postpartum CareAnxiety
Wolfson Medical Center 160
Not applicableUnknownNCT03787641
What this trial is testing

Systematic Evaluation of Protamine Doze in Cardiac Surgery

Who this might be right for
Cardiac Surgery With Cardiopulmonary Bypass
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 100
Not applicableUnknownNCT05382481
What this trial is testing

Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Xuanwu Hospital, Beijing 858
Not applicableStudy completedNCT00480636
What this trial is testing

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Who this might be right for
Acute Deep Vein Thrombosis
Pfizer 102
Not applicableStudy completedNCT06166914
What this trial is testing

Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment

Who this might be right for
Retinal DetachmentProliferative Vitreoretinopathy
Alexandria University 42
Large-scale testing (Phase 3)Enrolling By InvitationNCT04762992
What this trial is testing

LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)

Who this might be right for
Fetal Growth RetardationPrematurityPre-Eclampsia
Centro Hospitalar de Lisboa Central 12
Post-approval studies (Phase 4)Study completedNCT04373707
What this trial is testing

Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19

Who this might be right for
COVIDThrombosisPulmonary Embolism+1 more
Central Hospital, Nancy, France 1,000
Post-approval studies (Phase 4)Study completedNCT00203658
What this trial is testing

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

Who this might be right for
ThrombosisThromboembolismVenous Thrombosis
University of Calgary 400
Not applicableLooking for participantsNCT07464808
What this trial is testing

Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management

Who this might be right for
Venous Thromboembolic Event
Ain Shams University 25
Large-scale testing (Phase 3)Study completedNCT00986765
What this trial is testing

Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia

Who this might be right for
Preeclampsia
Assistance Publique - Hôpitaux de Paris 257
Not applicableStudy completedNCT01588171
What this trial is testing

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Who this might be right for
Venous Thromboembolic Diseases
Hawler Medical University 7,020
Large-scale testing (Phase 3)UnknownNCT02486666
What this trial is testing

Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose

Who this might be right for
Venous Thromboembolism
Hamilton Health Sciences Corporation 20
Post-approval studies (Phase 4)UnknownNCT03426982
What this trial is testing

Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring

Who this might be right for
Myocardial InfarctionVenous ThromboembolismStroke+1 more
Wuhan Asia Heart Hospital 700
Testing effectiveness (Phase 2)Study completedNCT02334007
What this trial is testing

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

Who this might be right for
Venous ThromboembolismLung NeoplasmsPulmonary Embolism
McMaster University 102
Very early researchEnded earlyNCT03100123
What this trial is testing

AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study

Who this might be right for
Antiphospholipid Syndrome in PregnancyPregnancy Loss
Ottawa Hospital Research Institute 1
Next Page